Creatinine Test Market Economic Impact, Dynamics and SWOT Analysis Till 2030
Creatinine
Test Market Overview
Market Research Future has assessed that the growth of the global
creatinine test market is expected to register at a CAGR of 8.7% during the
assessment period of 2022 to 2030. This moderate yet steady rate of growth is
expected to yield a market value of USD
2.5 Billion by the end of 2030. Creatinine tests are a range of tests that are
performed to ascertain creatinine levels in the blood. Creatinine itself is a
waste product from the breakdown of creatine which is consistently found in the body as a part of normal function. High
levels indicate kidney failure.
The high prevalence of
chronic kidney diseases due to poor urban lifestyles is expected to drive the
global Creatinine Test
Market. Moreover, market players
are actively advancing existing
technology for kidney function testing. As a result,
creatinine tests are increasingly accurate, thus driving the market. The
alarming increase in kidney diseases has
prompted government bodies to take initiatives in encouraging creatinine tests
so as to control the growth of chronic kidney diseases. The rising approval
from the FDA for creatinine tests is expected to drive the market toward new
opportunities for growth. Meanwhile, the false estimates that creatinine
testing sometimes provides is expected to hinder market growth over the forecasted period.
Segmentation
The global creatinine test market has been segmented based on test
type, product type, application, and end use. By test type, the global
creatinine test market has been segmented into urine test, creatinine clearance
test, and blood test. The blood test segment is expected to exhibit high growth
over the forecast period due to the growing preference for blood tests to
measure creatinine levels over other tests. The segment was valued at USD
211.83 Mn in 2016 and is expected to expand at a CAGR of 5.32% over the
forecast period. The urine test segment is expected to exhibit significant
growth over the forecast period on account of advances in urine test strips
which facilitate accurate diagnosis of kidney disorders.
By product type, market has been segmented into consumables and
instruments. The consumables segment is the largest segment while the
instruments segment is expected to be the fastest growing segment over the
forecast period. The instruments segment is expected to exhibit a CAGR of 6%
over the forecast period.
By application, the market has been segmented into kidney cancer,
renal failure, glomerulonephritis, urinary tract obstruction, and others. The
urinary tract obstruction segment is anticipated to expand at a CAGR of 5.10%
over the forecast period.
By end-use, the market has been segmented into research
institutes, diagnostic centers, hospitals and clinics, and others. The
diagnostic center's segment is expected
to exhibit a CAGR of 6.34% over the forecast period.
Regional
Analysis
Regions in the global creatinine market have been segmented into
the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa
(MEA).
The Americas account for the lion's share of the global creatinine
test market. A strong presence of healthcare industry leaders, extended
healthcare budget, improving reimbursement scenario and surging prevalence of
kidney disorders in the region favors the growth of the market.
Europe market is expected to register a CAGR of 6.12% over the
forecast period. Change in healthcare policies, the presence of sophisticated
healthcare infrastructure, and rapid adoption of advanced diagnostic methods
spur the growth of the Europe market. APAC is another significant market for
creatinine test. APAC and Europe collectively account for 51% share of the
global market. The APAC market is catalyzed by a large patient pool, brisk
adoption of the latest diagnostic methods, and improving healthcare
infrastructure in the region.
Key Players
global creatinine
test market Players include URIT Medical, Thermo Fisher
Scientific, Inc., OPTI Medical Systems, Siemens AG, Abbott, Abcam plc, ARKRAY,
Inc., F. Hoffmann-La Roche AG, ACON Laboratories, Inc., Quest Diagnostics, Nova
Biomedical, The Danaher Corporation, and others.
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting
Services. MRFR team have supreme objective to provide the optimum quality
market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research
and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
.jpg)
Comments
Post a Comment